4CPS-010 Reconciliation of eye drops for glaucoma in the emergency department

<h3>Background and Importance</h3> The recognition of glaucoma as a relevant medical problem on admission to the emergency department (ED) is variable. Most ophthalmic treatments are absorbed into the systemic circulation and their discontinuation may worsen this condition. For eye drops adjustment, the patient´s clinical situation and concomitant medications must be taken into account. <h3>Aim and Objectives</h3> To analyse the reconciliation of treatment for glaucoma at admission and to optimise the process. <h3>Material and Methods</h3> Interventional study that included patients diagnosed with glaucoma under treatment with eye drops who were admitted to the emergency observation ward during the pharmaceutical presence period (December 2023 to February 2024, Monday to Friday from 8 a.m. to 3 p.m.). Collected data included demographic variables, drug, glaucoma diagnostic record in patient‘s admission history and ophthalmic treatment reconciliation. A priori unjustified discrepancies between hospital and home prescriptions were classified as justified discrepancies (at the discretion of a physician) or as reconciliation errors (RE) if they resulted in a prescription modification after pharmacist’s intervention. The extent of pharmaceutical medication revision within 24 hours of admission to the ED was measured. <h3>Results</h3> A total of 49 eye drops prescriptions corresponding to 34 patients (50% men) with a median age of 79 (53–95) years were revised. There were 27 hospital prescriptions (55%) that did not require clarification, five (10%) justified discrepancies and 17 (35%) RE: 16 (94%) omissions and one (6%) inappropriate prescription (dorzolamide in a patient with severe renal failure). The most frequently prescribed drugs were: brinzolamide (27%), bimatoprost (16%), latanoprost (16%), dorzolamide-timolol (8%), brinzolamide-timolol (4%), carteolol (4%), timolol (4%), travoprost (4%). There was no glaucoma diagnostic record in the admission history of 12 (35%) patients. In seven of them, eye drops omissions were detected, which resulted in RE in all cases. A total of 28 (82%) patients were revised by pharmacists within 24h after hospitalisation. The others were admitted on Saturday or remained previously more than 24h in other ED subunits without a pharmacist. <h3>Conclusion and Relevance</h3> In the ED there is room for improvement in the reconciliation of eye drops for glaucoma and in its consideration as a relevant medical problem that requires correct anamnesis and pharmacotherapeutic follow-up. Pharmaceutical presence improves ophthalmic treatment reconciliation and provided healthcare. <h3>References and/or Acknowledgements</h3> <h3>Conflict of Interest</h3> No conflict of interest